Chorus

BioAge Labs Announces Plans for Phase 2 Trial of First-in-Class Apelin Receptor Agonist BGE-105/Azelaprag Co-Administered With Tirzepatide for Treatment of Obesity, in Collaboration With Lilly’s Chorus Organization

Retrieved on: 
Thursday, October 26, 2023

As part of the collaboration, Lilly will also provide BioAge with tirzepatide.

Key Points: 
  • As part of the collaboration, Lilly will also provide BioAge with tirzepatide.
  • “We are thrilled to work directly with the clinical development experts at Chorus and benefit from Lilly’s expertise in obesity drug development,” said Kristen Fortney, PhD, CEO and co-founder of BioAge.
  • “Our Phase 2 trial is designed to assess whether azelaprag can substantially increase the weight loss achieved with drugs of the incretin class.
  • Apelin signaling has demonstrated multiple benefits in energy metabolism in mouse models, including increased insulin sensitivity and reduction in fat mass.

Jazz wins Award of Excellence at Canada's Safest Employers awards

Retrieved on: 
Friday, October 20, 2023

HALIFAX, NS, Oct. 20, 2023 /CNW/ - Chorus Aviation Inc. ('Chorus') (TSX: CHR) is proud to announce that subsidiary Jazz Aviation LP ('Jazz') was named among Canada's Safest Employers 2023, as an Award of Excellence winner in the Public Transportation category.

Key Points: 
  • HALIFAX, NS, Oct. 20, 2023 /CNW/ - Chorus Aviation Inc. ('Chorus') (TSX: CHR) is proud to announce that subsidiary Jazz Aviation LP ('Jazz') was named among Canada's Safest Employers 2023, as an Award of Excellence winner in the Public Transportation category.
  • "Congratulations to the Jazz team on this safety excellence recognition," said Colin Copp, President and Chief Executive Officer, Chorus.
  • This is Jazz's seventh consecutive year accepting awards at the Canada's Safest Employers event.
  • Launched in 2011, Canada's Safest Employers awards recognize organizations with outstanding accomplishments in promoting the health and safety of their employees.

The Frederick Arts Council Awards $50,000 to Local Arts Organizations

Retrieved on: 
Thursday, October 12, 2023

FREDERICK, Md. , Oct. 12, 2023 /PRNewswire-PRWeb/ -- The Frederick Arts Council announces that it has awarded $50,000 in Create and Activate Now (C.A.N.) Recover awards to arts organizations throughout Frederick County.

Key Points: 
  • Recover grants to local arts organizations which will continue to benefit the community as a whole," said Louise Kennelly, Executive Director of the Frederick Arts Council.
  • The FAC has awarded subgrants to the following local arts organizations: Choral Arts Society of Frederick, Emmitsburg Community Chorus, Endangered Species (theatre) Project, Frederick Book Arts Center, Frederick Regional Youth Orchestra, Frederick Symphony Orchestra, Fredericktowne Players, Maryland Ensemble Theatre, Maryland Wind Festival, Other Voices, Potters' Guild of Frederick, Clustered Spires Chorus, The Delaplaine Arts Center, Frederick Children's Chorus, the Frederick Chorale, Global Z Recording Project, National String Symphonia, Weinberg Center for the Arts, and City Youth Matrix.
  • This funding opportunity has been made possible through a National Endowment for the Arts (NEA) American Rescue Plan (ARP) Grant to Local Arts Agencies (LAA) awarded to the Frederick Arts Council for sub-granting.
  • Recover grants to local arts organizations which will continue to benefit the community as a whole" said Louise Kennelly, Executive Director of the Frederick Arts Council.

Chorus by ZoomInfo Releases New Generative AI Solution That Eliminates Drafting Follow-Up Emails

Retrieved on: 
Thursday, September 28, 2023

The new generative AI follow-up emails, an extension of ZoomInfo’s previous work turning meeting transcripts into millions of actionable post-meeting memos , are part of several new Chorus features and product highlights aimed at simplifying workflows.

Key Points: 
  • The new generative AI follow-up emails, an extension of ZoomInfo’s previous work turning meeting transcripts into millions of actionable post-meeting memos , are part of several new Chorus features and product highlights aimed at simplifying workflows.
  • ZoomInfo’s latest application of generative AI technology means that meeting organizers no longer have to sift through extensive notes and craft follow-up emails to keep projects and people aligned.
  • Since its introduction in May, Chorus users have relied on the post-meeting briefs feature to produce more than 2.3 million generative AI meeting summaries.
  • “These Chorus innovations, powered by generative AI, are ushering in the next generation of getting deals done,” said Dominik Facher, Chief Product Officer at ZoomInfo.

An Automated Peptide Synthesis and Purification Platform to Overcome Operational Complexity, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, September 28, 2023

 TORONTO, Sept. 28, 2023 /PRNewswire-PRWeb/ -- Traditional peptide synthesis workflows rely on separate synthesis and purification machines, which pose challenges in terms of speed and throughput, as well as the complexity of the hardware setup and operation from start to finish. However, to facilitate the development of novel peptide drugs, peptide developers need simple, integrated and parallel solutions without sacrificing process reliability and robustness.

Key Points: 
  • In this free webinar, attendees will gain insights into how to reduce complexity in the lab by performing peptide synthesis and purification in a single instrument.
  • Learn about induction heating for fast synthesis of even the most complex peptides and the benefits of catch-and-release purification to improve operational reliability.
  • However, to facilitate the development of novel peptide drugs, peptide developers need simple, integrated and parallel solutions without sacrificing process reliability and robustness.
  • Don't miss this opportunity to hear first-hand how cutting-edge peptide synthesis and purification technology can revolutionize the peptide processes from start to finish.

Reveal Group Awarded Approved Partner Status for SS&C Blue Prism Document Automation

Retrieved on: 
Tuesday, September 26, 2023

Reveal Group, a leading provider of intelligent automation services in North America, proudly announces attaining SS&C Blue Prism Document Automation Approved Status.

Key Points: 
  • Reveal Group, a leading provider of intelligent automation services in North America, proudly announces attaining SS&C Blue Prism Document Automation Approved Status.
  • Building on a decade-long partnership, Reveal Group is the first SS&C Blue Prism partner to achieve this status and implement the solution for a valued client.
  • “SS&C Blue Prism is excited to have the Reveal Group attain the SS&C Blue Prism Document Automation Partner Status,” said Daud Yamin, V.P.
  • In addition to the SS&C Blue Prism Document Automation Approved Partner Status, Reveal Group’s impressive list of achievements includes the SS&C Blue Prism Cloud Approved status as well as triple certifications of Platinum Capability, Platinum Delivery, and Silver Managed Service Provider status.

Chinese and American teenagers sing for peace on the Int'l Day of Peace

Retrieved on: 
Sunday, September 24, 2023

GUANGZHOU, China, Sept. 22, 2023 /PRNewswire/ -- A report from GDToday: 

Key Points: 
  • As a steamer blows its whistle, it changes into a peace dove that is flying across the Pacific Ocean.
  • Teenagers from the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) and New York presented a virtual chorus together.
  • The International Day of Peace, observed around the world annually on 21 September, was adopted by a resolution of the United Nations General Assembly.
  • Meanwhile, the 3rd Guangdong-Hong Kong-Macao Greater Bay Area Culture & Arts Festival fired up the passion for art in the bay areas.

Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development

Retrieved on: 
Friday, September 22, 2023

Chime Biologics and Panolos Bioscience have entered into a global strategic collaboration agreement on a novel multi-specific protein drug.

Key Points: 
  • Chime Biologics and Panolos Bioscience have entered into a global strategic collaboration agreement on a novel multi-specific protein drug.
  • Chime Biologics will provide development and manufacturing services to Panolos Bioscience for PB203, a next-generation immuno-oncology drug.
  • Dr. HyeSeong Lim, Founder and CEO of Panolos Bioscience, and Mr. YoungHoon Cho, Chief Business Officer of Panolos Bioscience, as well as Chime Biologics' team attended the signing ceremony.
  • We believe that Chime Biologics' high-quality platform and rich experience will facilitate the global R&D, clinical trials and future commercial manufacturing of multi-specific therapeutic proteins."

Chorus Innovations Selected as an Approved Vendor for California's PATH Technical Assistance Marketplace

Retrieved on: 
Tuesday, September 19, 2023

LONG BEACH, Calif., Sept. 19, 2023 /PRNewswire/ -- Chorus Innovations, a public-sector health and behavioral health software company, today announced that it has been selected by the State of California's Department of Health Care Services (DHCS) to provide hands-on assistance for the Providing Access and Transforming Health (PATH) Technical Assistance (TA) Marketplace. This designation enables eligible entities to receive state-funded access to Chorus' technical expertise. The PATH TA Marketplace is designed to stimulate and accelerate the provision of vital Enhanced Care Management (ECM) and Community Supports, both of which are critical pillars of California's Medi-Cal transformation efforts to improve health outcomes.

Key Points: 
  • This designation enables eligible entities to receive state-funded access to Chorus' technical expertise.
  • Eligible entities include community-based organizations, government agencies, provider organizations, as well as others that may be approved by DHCS.
  • A detailed step by step illustration of the application process is available at the "Reference Materials" section of the TA Marketplace website .
  • Chorus' selection underscores the value of its unique development approach, which pairs clinically-validated participatory development techniques along with the Chorus rapid technology development platform.

Enterprises Running Revenue on Clari’s Platform Win 24% More Deals, Achieve Gains Across Every Major Revenue Metric

Retrieved on: 
Thursday, August 3, 2023

Increasingly they are adopting Clari to stop revenue leak, drive faster time to revenue, and win every revenue moment.

Key Points: 
  • Increasingly they are adopting Clari to stop revenue leak, drive faster time to revenue, and win every revenue moment.
  • Among the new customers adopting Clari to transform their revenue process are Iron Mountain, Pearson, Rocket Software, Remote, Secureframe, Orca Security, and Lavender.
  • “The thing that got me most excited when I truly understood Clari’s capabilities is that it’s a true platform.
  • “Running revenue with precision, enterprise-wide, requires more than best-in-class technology,” said Clari Director of Customer Education, Scott K. Wilder.